Torrent Pharmaceuticals Limited (Torrent Pharmaceuticals) is an Indian pharmaceutical company engaged in the development, manufacture, and marketing of a wide range of pharmaceutical formulations and active pharmaceutical ingredients (APIs). The comp…
Analysis
Hope premium
Torrent Pharmaceuticals Limited is priced well ahead of what the underlying numbers justify, a pattern we describe as a hope premium.
On valuation, the picture is expensive. The owner-earnings multiple stands at 55.9×; owner earnings: the cash an owner could take out each year. The implied growth embedded in that price is around 20% a year, against analyst forecasts of 21%. The price, in other words, assumes less than the experts do.
Growth is solid; the safety picture is stretched. The company scores 10/20 on our value-creation score: creating some value. Analyst sentiment is cautious.
No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.
360° rank · history
1007550250
Jan 20239
20
2023202420252026
All-time high
37
Jan 2024
All-time low
9
Jan 2023
Average rank
21
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Current202520242023
Price/Sales
8
11
25
33
Price/Earnings
5
19
22
33
Price/Book
6
10
14
34
Dividend Yield
57
50
53
51
Value (overall)
12
13
21
39
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.